Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
aAKDS-M
- Development stage
- Unknown
- Lead developer
- SPA Microgen
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
aAKDS-M is Russia's first combined diphtheria, tetanus, and pertussis (DTP) vaccine specifically developed for adults. Created by NPO Microgen (a subsidiary of Nacimbio under Rostec), the vaccine contains reduced amounts of diphtheria and tetanus toxoids along with an acellular pertussis component (Tdap). It is indicated for active immunization and booster vaccination in individuals aged 18 to 60 years. The vaccine works by inducing the production of protective antibodies against the toxins produced by *Corynebacterium diphtheriae* and *Clostridium tetani*, as well as antigens from *Bordetella pertussis*. Clinical trials involving 436 volunteers demonstrated high safety, excellent tolerability, and the development of protective antibody titers, leading to its approval under EAEU regulations.
- Other names
- Diphtheria-tetanus-pertussis (DTP) vaccine for adultsFirst Russian DTP vaccine for adultsаАКДС-М
02
Targets
Diphtheria toxin
Beyond the preview
Go deeper on aAKDS-M.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on aAKDS-M.